Updates

GAN

June 2020

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

Shares in GAN, the gambling software provider, have now gone public on NASDAQ. Trading started on 5 May under the ticker “GAN” and contemporaneously the AIM listing was cancelled. With business prospects boosted by higher than expected momentum for real money gambling in New Jersey and Pennsylvania, it was able to increase the amount raised to US$54m by offering 6.4m new shares at US$8.50, the high end of the range of US$6.50-US$8.50. Every four shares held on AIM have been consolidated to one share in GAN Limited. After a strong opening pop (+40%), the shares have carried on climbing and currently trade at US$15.07 - equivalent to 306p for “old” GAN. I highlighted the shares at 51.5p in the M ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Dart Group

Filta Group - Launches COVID-19 sanitisation service

GAN - Banking a gain of 832% (September 2020)

GAN (April 2020)

GAN (March 2020)

GAN - Shares explode upwards after H1 significantly ahead of expectations (October 2019)

GAN (May 2019)

GAN - Paddy Power Betfair to launch sports betting in Pennsylvania and West Virginia (March 2019)

GAN - Gets to keep 10% of real money gaming revenue (September 2018)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

GAN